PAIA
ZBH icon

Park Avenue Institutional Advisers’s Zimmer Biomet ZBH Stock Holding History

Park Avenue Institutional Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,162
Closed -$136K – 431
2016
Q2 		$136K Hold
1,162
– – 0.12% 213
2016
Q1 		$120K Buy
1,162
+14
+1% +$1.35K 0.1% 234
2015
Q4 		$114K Sell
1,148
-21
-2% -$2.06K 0.1% 243
2015
Q3 		$107K Sell
1,169
-11
-0.9% -$1.1K 0.09% 253
2015
Q2 		$125K Buy
+1,180
New +$131K 0.1% 238

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Avenue Institutional Advisers's ZBH Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 1,162 shares — an estimated $136K sold.

Park Avenue Institutional Advisers first reported a position in ZBH in Q2 2015 and held it in 5 quarters. The position peaked at $136K in Q2 2016. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 1,162 Zimmer Biomet shares in Q3 2016, an estimated $136K.
  • Park Avenue Institutional Advisers first reported a position in Zimmer Biomet in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Zimmer Biomet position peaked at $136K in Q2 2016.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.